- Home
- PAC vs ICLR Comparison
PAC vs ICLR Comparison
Compare PAC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAC
- ICLR
- Stock Information
- Founded
- PAC 1998
- ICLR 1990
- Country
- PAC Mexico
- ICLR Ireland
- Employees
- PAC N/A
- ICLR N/A
- Industry
- PAC Aerospace
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PAC Consumer Discretionary
- ICLR Health Care
- Exchange
- PAC Nasdaq
- ICLR Nasdaq
- Market Cap
- PAC 10.4B
- ICLR 11.6B
- IPO Year
- PAC 2006
- ICLR 1998
- Fundamental
- Price
- PAC $233.25
- ICLR $150.10
- Analyst Decision
- PAC Buy
- ICLR Buy
- Analyst Count
- PAC 6
- ICLR 12
- Target Price
- PAC $207.50
- ICLR $204.18
- AVG Volume (30 Days)
- PAC 122.8K
- ICLR 1.2M
- Earning Date
- PAC 07-22-2025
- ICLR 07-23-2025
- Dividend Yield
- PAC 3.11%
- ICLR N/A
- EPS Growth
- PAC N/A
- ICLR 11.53
- EPS
- PAC 0.86
- ICLR 9.19
- Revenue
- PAC $1,435,598,195.00
- ICLR $8,192,621,999.00
- Revenue This Year
- PAC $57.91
- ICLR N/A
- Revenue Next Year
- PAC $8.28
- ICLR $2.10
- P/E Ratio
- PAC $27.03
- ICLR $16.33
- Revenue Growth
- PAC 14.67
- ICLR N/A
- 52 Week Low
- PAC $146.62
- ICLR $125.10
- 52 Week High
- PAC $241.62
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- PAC 58.51
- ICLR 60.50
- Support Level
- PAC $225.18
- ICLR $142.89
- Resistance Level
- PAC $237.15
- ICLR $155.25
- Average True Range (ATR)
- PAC 5.38
- ICLR 4.79
- MACD
- PAC 0.36
- ICLR 0.51
- Stochastic Oscillator
- PAC 84.13
- ICLR 65.78
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.